January 16, 2025
This registry study is collecting real-world data on patients with advanced, EGFR-positive non-small cell lung cancer who may not have had the opportunity, wanted to, or been eligible to enroll in a trial
January 5, 2023
This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
December 15, 2021
This study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation
September 20, 2021
A new language guide encourages respect, eliminates blame, and promotes health equity